Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

about

A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.

P2860

Q49165105-81FE2580-F9EB-476F-BC12-400832692BE0 Q52345516-0576D457-F7BB-4FD6-9FAC-D5FE684552C6

P2860

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q41701996

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

@en

type

Item

label

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

@en

prefLabel

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

@en

P1476

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

@en

P2093

Cun Gao

http://www.w3.org/2001/XMLSchema#string

Hui Tian

http://www.w3.org/2001/XMLSchema#string

Lei Qi

http://www.w3.org/2001/XMLSchema#string

Libo Si

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Shuhai Li

http://www.w3.org/2001/XMLSchema#string

Weiming Yue

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs: target recognition and regulatory functions

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma

MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Poor prognosis patients with inoperable locally advanced NSCLC and large tumors benefit from palliative chemoradiotherapy: a subset analysis from a randomized clinical phase III trial.

miR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type.

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.

P304

4325-4330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6667

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28943946

http://www.w3.org/2001/XMLSchema#string

P932

5604169

http://www.w3.org/2001/XMLSchema#string

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

about

P2860

P2860

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932